Valuation dashboard for Stereotaxis, Inc. (STXS) with P/E N/A, P/B 7.04, EV/EBITDA -5.77 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
Analysis Summary
Stereotaxis, Inc. reported revenue of $32.4M in the most recent fiscal year, growing at a 5-year CAGR of 4.0%.
Trailing-twelve-month margins: gross margin 55.6%, operating margin -73.0%, net margin -74.2%.
At the current price of $1.32, STXS has negative trailing earnings (P/E not meaningful) and an ROE of -132.62%. Market capitalisation stands at $129M.
Balance sheet quality for STXS: current ratio of 1.5. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 7.04 |
| EV / EBITDA | -5.77 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-2.15 |
| vs Current Price | -262.5% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| STXS | Stereotaxis, Inc. | $129M | 7.04 | -132.6% | |
| 0R29.L | Intuitive Surgical, Inc. | $135.9B | 74.05 | 11.86 | 17.8% |
| ISRG | Intuitive Surgical, Inc. | $135.1B | 44.13 | 7.62 | 17.8% |
| 0R19.L | Becton, Dickinson and Company | $52.5B | 33.21 | 2.19 | 6.6% |
| BDX | Becton, Dickinson and Company | $49.0B | 54.89 | 2.05 | 3.8% |
| RMD | ResMed Inc. | $33.1B | 22.81 | 5.23 | 23.9% |
| 0KW4.L | ResMed Inc. | $31.1B | |||
| MDLN | Medline Inc. | $27.6B | 38.36 | 2.44 | 10.8% |
Price
| Price | $1.32 |
| Market Cap | $129M |
| Exchange | AMEX |
| Country | US |
Profitability
| Return on Equity | -132.62% |
| Return on Invested Capital | -74.49% |
| Return on Assets | -40.16% |
| Gross Margin | 55.57% |
| Operating Margin | -73.02% |
| Net Margin | -74.24% |
Related companies: ARCT · CVRX · HUMA · MDXH · NEO · OSUR · QTRX
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of STXS: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks